Bioanalytics – Chemical

Prologue: Rising to the Challenge: Advances in Mass Spectrometry Enabling the Future of Biomarker and Biotherapeutic Analysis

Prologue Speaker(s)

• 

  Chad Briscoe, PhD

  Scientific Officer / VP Business Development Europe
  BioAgilytix Labs
  Raleigh, North Carolina

  Handouts

Drug development has grown increasingly complex in recent years. New chemical modalities have emerged treating and curing diseases thought unimaginable just a short time ago. Increasingly complex modalities have been achievable only by a revolution in all areas of drug development including Bioanalytics. Mass Spectrometry, as one of the core measurement technologies in Bioanalysis, is being utilized to help enable many of these advances. Quantification of biotherapeutics and large molecule biomarkers utilizing mass spectrometry don’t follow the traditional small molecule workflows. The complexity of the workflows and the new tools available to utilize in these processes have been in a constant evolution. This session will highlight these best practice workflows in biotherapeutic and biomarker analysis. It will also highlight some of the applications where Mass Spectrometry has been used to make an impact on this increasingly complex and challenging field.